Similar Search Results

Vision-Specific Instruments for the Assessment of Health-Related Quality of Life and Visual Functioning: A Literature Review

Margolis, Mary Kay; Coyne, Karin; Kennedy-Martin, Tessa; … - In: PharmacoEconomics 20 (2002) 12, pp. 791-812

. Visual impairment has been shown to have negative effects on health-related quality of life (HR-QOL) and a significant impact …-specific instruments assessing visual functioning and/or the impact of visual impairment on HR-QOL or daily activities. Issues relevant to …

Persistent link: https://www.econbiz.de/10005590544

Cost-Effectiveness of Alendronate in the Treatment of Osteoporosis in Denmark - An Economic Evaluation Based on the Fracture Intervention Trial

Jönsson, Linus; Borgström, Fredrik; Zethraeus, Niklas - Economics Institute for Research (SIR), … - 2002

Background: The Fracture Intervention Trial (FIT) showed that the bisphosphonate alendronate reduces the risk of fractures in women with low bone mass in the United States. <p> Objective: To estimate the cost-effectiveness (cost per life-year gained and cost per quality-adjusted life-year, QALY,...</p>

Persistent link: https://www.econbiz.de/10005771182

An Independent Practice Association-Supported Disease Management Program: Impact on Patients with Coronary Artery Disease

Cannon-Wagner, Miriam; Soule, Diane S.; Walker, David R.; … - In: Disease Management and Health Outcomes 10 (2002) 9, pp. 571-577

Background: Disease management has been shown to improve outcomes in patients with chronic diseases such as coronary artery disease (CAD). Yet Independent Practice Associations (IPA) have expressed concern with the promise of disease management (DM) to improve patient outcomes. Managed care...

Persistent link: https://www.econbiz.de/10005448751

Improving Quality of Life for Patients with Angina Pectoris: A Team Approach to Disease Management

Cupples, Margaret E.; Dempster, Martin - In: Disease Management and Health Outcomes 9 (2001) 9, pp. 473-481

The evaluation of outcome of management of patients with angina pectoris is now inextricably linked with an assessment of quality of life. Angina pectoris, as a manifestation of coronary heart disease, is a major cause of morbidity and mortality in many countries. Optimal management of patients...

Persistent link: https://www.econbiz.de/10005448770

Cost Estimates for Chronic Diseases

Woo, Jean; Cockram, Clive - In: Disease Management and Health Outcomes 8 (2000) 1, pp. 29-41

With increasing chronic disease and disability burden as a result of the aging of populations worldwide, cost estimates of disease and disability are important in determining: 1. the most cost-effective methods in delivering healthcare in order to maximise resources; and 2. health policies and...

Persistent link: https://www.econbiz.de/10005448788

Adolfsson, Jan - In: PharmacoEconomics 21 (2003) 4, pp. 241-247

Health-related quality of life (HR-QOL) research, in general, is developing. It is becoming increasingly recognised as being important and knowledge on how to assess HR-QOL is spreading. Modern HR-QOL research should assess prevalence and severity of symptoms or functions, as well as the bother...

Persistent link: https://www.econbiz.de/10005449039

Treatment of Atopic Dermatitis and Impact on Quality of Life: A Review with Emphasis on Topical Non-Corticosteroids

Schiffner, Roman; Schiffner-Rohe, Julia; Landthaler, Michael - In: PharmacoEconomics 21 (2003) 3, pp. 159-179

review the present literature is analysed concerning impact on quality of life for topically-applicable alternatives to the … increase in impact on quality of life. Since studies used different QOL measurements and vary in inclusion criteria, treatment … active treatment modalities and their impact on quality of life. Consensus meetings are desirable to formulate guidelines for …

Persistent link: https://www.econbiz.de/10005449047

Quality-of-Life Assessment in Comparative Therapeutic Trials and Causal Structure Considerations in Peripheral Occlusive Arterial Disease

Lehert, Philippe - In: PharmacoEconomics 19 (2001) 2, pp. 121-130

When considering the use of quality of life as a primary end-point in phase III to IV comparative trials, the trial designer generally faces some unresolved questions. These include: How does one explain that some dimensions [quality-of-life (QOL) instruments usually have more than 1 dimension]...

Persistent link: https://www.econbiz.de/10005449116

Reporting Heterogeneity in the Measurement of Health and Health-Related Quality of Life

Shmueli, Amir - In: PharmacoEconomics 20 (2002) 6, pp. 405-412

Objective: To investigate heterogeneity (systematic and observable variation) in health or health-related quality-of-life reports across population groups, for a given level of `true health'. Design: The investigators undertook full sit-down face-to-face interviews with 1999 individuals...

Persistent link: https://www.econbiz.de/10005449133

Arpinelli, Fabio; Visona, Giovanni; Bruno, Raffaele; … - In: PharmacoEconomics 18 (2000) 1, pp. 63-72

Objective: To investigate the psychometric performance and clinical validity of the 36-Item Short Form (SF-36) health survey when completed by asymptomatic HIV-positive Italian patients and to compare their health profile with a representative sample of 2031 Italian citizens (the Italian norm)....

Persistent link: https://www.econbiz.de/10005449147